Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210)

 I10R1_HUMAN             Reviewed;         578 AA.
Q13651; A8K6I0; B0YJ27;
15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
08-FEB-2011, sequence version 2.
18-JUL-2018, entry version 162.
RecName: Full=Interleukin-10 receptor subunit alpha;
Short=IL-10 receptor subunit alpha;
Short=IL-10R subunit alpha;
Short=IL-10RA;
AltName: Full=CDw210a;
AltName: Full=Interleukin-10 receptor subunit 1;
Short=IL-10R subunit 1;
Short=IL-10R1;
AltName: CD_antigen=CD210;
Flags: Precursor;
Name=IL10RA; Synonyms=IL10R;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLY-351.
TISSUE=Lymphoma;
PubMed=8120391;
Liu Y., Wei S.H.-Y., Ho A.S.-Y., de Waal Malefyt R., Moore K.W.;
"Expression cloning and characterization of a human IL-10 receptor.";
J. Immunol. 152:1821-1829(1994).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-61; ILE-113;
GLY-159; GLN-212; GLY-351 AND LEU-420.
SeattleSNPs variation discovery resource;
Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
NHLBI resequencing and genotyping service (RS&G);
Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-351.
TISSUE=Placenta;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16554811; DOI=10.1038/nature04632;
Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
Sakaki Y.;
"Human chromosome 11 DNA sequence and analysis including novel gene
identification.";
Nature 440:497-500(2006).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLY-351.
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-351.
TISSUE=Blood;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
PROTEIN SEQUENCE OF 22-36.
PubMed=15340161; DOI=10.1110/ps.04682504;
Zhang Z., Henzel W.J.;
"Signal peptide prediction based on analysis of experimentally
verified cleavage sites.";
Protein Sci. 13:2819-2824(2004).
[9]
X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 22-235 IN COMPLEX WITH IL10,
AND DISULFIDE BONDS.
PubMed=11485736; DOI=10.1016/S1074-7613(01)00169-8;
Josephson K., Logsdon N.J., Walter M.R.;
"Crystal structure of the IL-10/IL-10R1 complex reveals a shared
receptor binding site.";
Immunity 15:35-46(2001).
[10]
X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 22-235 IN COMPLEX WITH
CYTOMEGALOVIRUS IL10.
PubMed=12093920; DOI=10.1073/pnas.152147499;
Jones B.C., Logsdon N.J., Josephson K., Cook J., Barry P.A.,
Walter M.R.;
"Crystal structure of human cytomegalovirus IL-10 bound to soluble
human IL-10R1.";
Proc. Natl. Acad. Sci. U.S.A. 99:9404-9409(2002).
[11]
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 22-335 IN COMPLEX WITH IL10
AND EPSTEIN-BARR VIRUS IL10.
PubMed=15837194; DOI=10.1016/j.str.2005.01.016;
Yoon S.I., Jones B.C., Logsdon N.J., Walter M.R.;
"Same structure, different function crystal structure of the Epstein-
Barr virus IL-10 bound to the soluble IL-10R1 chain.";
Structure 13:551-564(2005).
[12]
VARIANTS IBD28 ILE-84 AND ARG-141.
PubMed=19890111; DOI=10.1056/NEJMoa0907206;
Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schaffer A.A.,
Noyan F., Perro M., Diestelhorst J., Allroth A., Murugan D.,
Hatscher N., Pfeifer D., Sykora K.W., Sauer M., Kreipe H., Lacher M.,
Nustede R., Woellner C., Baumann U., Salzer U., Koletzko S., Shah N.,
Segal A.W., Sauerbrey A., Buderus S., Snapper S.B., Grimbacher B.,
Klein C.;
"Inflammatory bowel disease and mutations affecting the interleukin-10
receptor.";
N. Engl. J. Med. 361:2033-2045(2009).
[13]
VARIANTS IBD28 CYS-91; TRP-101; HIS-117 AND CYS-262.
PubMed=23839161; DOI=10.1097/MEG.0b013e328361a4f9;
Shim J.O., Hwang S., Yang H.R., Moon J.S., Chang J.Y., Ko J.S.,
Park S.S., Kang G.H., Kim W.S., Seo J.K.;
"Interleukin-10 receptor mutations in children with neonatal-onset
Crohn's disease and intractable ulcerating enterocolitis.";
Eur. J. Gastroenterol. Hepatol. 25:1235-1240(2013).
[14]
VARIANTS IBD28 ARG-69; CYS-91; TRP-101; HIS-117 AND CYS-262.
PubMed=24785691; DOI=10.1038/jhg.2014.32;
Shim J.O., Seo J.K.;
"Very early-onset inflammatory bowel disease (IBD) in infancy is a
different disease entity from adult-onset IBD; one form of
interleukin-10 receptor mutations.";
J. Hum. Genet. 59:337-341(2014).
-!- FUNCTION: Receptor for IL10; binds IL10 with a high affinity.
-!- INTERACTION:
P03180:BCRF1 (xeno); NbExp=4; IntAct=EBI-1031656, EBI-1042167;
P22301:IL10; NbExp=9; IntAct=EBI-1031656, EBI-1031632;
P03495:NS (xeno); NbExp=2; IntAct=EBI-1031656, EBI-2548993;
P17150:UL111A (xeno); NbExp=2; IntAct=EBI-1031656, EBI-1033736;
-!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
protein.
-!- TISSUE SPECIFICITY: Spleen, thymus, and PBMC. Weak expression in
pancreas, skeletal muscle, brain, heart, and kidney. Placenta,
lung, and liver showed intermediate levels. Monocytes, B-cells,
large granular lymphocytes, and T-cells express high levels.
-!- DISEASE: Inflammatory bowel disease 28 (IBD28) [MIM:613148]: A
chronic, relapsing inflammation of the gastrointestinal tract with
a complex etiology. It is subdivided into Crohn disease and
ulcerative colitis phenotypes. Crohn disease may affect any part
of the gastrointestinal tract from the mouth to the anus, but most
frequently it involves the terminal ileum and colon. Bowel
inflammation is transmural and discontinuous; it may contain
granulomas or be associated with intestinal or perianal fistulas.
In contrast, in ulcerative colitis, the inflammation is continuous
and limited to rectal and colonic mucosal layers; fistulas and
granulomas are not observed. Both diseases include extraintestinal
inflammation of the skin, eyes, or joints.
{ECO:0000269|PubMed:19890111, ECO:0000269|PubMed:23839161,
ECO:0000269|PubMed:24785691}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the type II cytokine receptor family.
{ECO:0000305}.
-!- WEB RESOURCE: Name=SeattleSNPs;
URL="http://pga.gs.washington.edu/data/il10ra/";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; U00672; AAA17896.1; -; mRNA.
EMBL; AY195619; AAN86349.1; -; Genomic_DNA.
EMBL; EF444988; ACA06005.1; -; Genomic_DNA.
EMBL; AK291645; BAF84334.1; -; mRNA.
EMBL; AP002962; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471065; EAW67343.1; -; Genomic_DNA.
EMBL; BC028082; AAH28082.1; -; mRNA.
CCDS; CCDS8388.1; -.
PIR; I56215; I56215.
RefSeq; NP_001549.2; NM_001558.3.
UniGene; Hs.504035; -.
PDB; 1J7V; X-ray; 2.90 A; R=22-235.
PDB; 1LQS; X-ray; 2.70 A; R/S=22-235.
PDB; 1Y6K; X-ray; 2.52 A; R=22-235.
PDB; 1Y6M; X-ray; 2.80 A; R=22-235.
PDB; 1Y6N; X-ray; 2.70 A; R=22-235.
PDB; 5IXI; X-ray; 2.57 A; B=263-303.
PDBsum; 1J7V; -.
PDBsum; 1LQS; -.
PDBsum; 1Y6K; -.
PDBsum; 1Y6M; -.
PDBsum; 1Y6N; -.
PDBsum; 5IXI; -.
ProteinModelPortal; Q13651; -.
SMR; Q13651; -.
BioGrid; 109801; 4.
CORUM; Q13651; -.
DIP; DIP-3512N; -.
IntAct; Q13651; 23.
MINT; Q13651; -.
STRING; 9606.ENSP00000227752; -.
GuidetoPHARMACOLOGY; 1727; -.
iPTMnet; Q13651; -.
PhosphoSitePlus; Q13651; -.
BioMuta; IL10RA; -.
DMDM; 322510034; -.
PaxDb; Q13651; -.
PeptideAtlas; Q13651; -.
PRIDE; Q13651; -.
ProteomicsDB; 59648; -.
DNASU; 3587; -.
Ensembl; ENST00000227752; ENSP00000227752; ENSG00000110324.
GeneID; 3587; -.
KEGG; hsa:3587; -.
UCSC; uc001prv.5; human.
CTD; 3587; -.
DisGeNET; 3587; -.
EuPathDB; HostDB:ENSG00000110324.9; -.
GeneCards; IL10RA; -.
H-InvDB; HIX0010172; -.
HGNC; HGNC:5964; IL10RA.
MalaCards; IL10RA; -.
MIM; 146933; gene.
MIM; 613148; phenotype.
neXtProt; NX_Q13651; -.
OpenTargets; ENSG00000110324; -.
Orphanet; 238569; Autosomal recessive early-onset inflammatory bowel disease.
PharmGKB; PA29779; -.
eggNOG; ENOG410IGAG; Eukaryota.
eggNOG; ENOG410YMSK; LUCA.
GeneTree; ENSGT00510000048847; -.
HOGENOM; HOG000112980; -.
HOVERGEN; HBG052056; -.
InParanoid; Q13651; -.
KO; K05134; -.
OMA; TEEPQFL; -.
OrthoDB; EOG091G04DG; -.
PhylomeDB; Q13651; -.
TreeFam; TF334107; -.
Reactome; R-HSA-6783783; Interleukin-10 signaling.
SignaLink; Q13651; -.
SIGNOR; Q13651; -.
ChiTaRS; IL10RA; human.
EvolutionaryTrace; Q13651; -.
GeneWiki; Interleukin_10_receptor,_alpha_subunit; -.
GenomeRNAi; 3587; -.
PRO; PR:Q13651; -.
Proteomes; UP000005640; Chromosome 11.
Bgee; ENSG00000110324; -.
CleanEx; HS_IL10RA; -.
ExpressionAtlas; Q13651; baseline and differential.
Genevisible; Q13651; HS.
GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
GO; GO:0019969; F:interleukin-10 binding; IEA:Ensembl.
GO; GO:0004920; F:interleukin-10 receptor activity; IBA:GO_Central.
GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
GO; GO:0050807; P:regulation of synapse organization; IEA:Ensembl.
GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
Gene3D; 2.60.40.10; -; 2.
InterPro; IPR003961; FN3_dom.
InterPro; IPR036116; FN3_sf.
InterPro; IPR013783; Ig-like_fold.
Pfam; PF01108; Tissue_fac; 1.
SUPFAM; SSF49265; SSF49265; 2.
1: Evidence at protein level;
3D-structure; Complete proteome; Direct protein sequencing;
Disease mutation; Disulfide bond; Glycoprotein; Membrane;
Polymorphism; Receptor; Reference proteome; Signal; Transmembrane;
Transmembrane helix.
SIGNAL 1 21 {ECO:0000269|PubMed:15340161}.
CHAIN 22 578 Interleukin-10 receptor subunit alpha.
/FTId=PRO_0000011012.
TOPO_DOM 22 235 Extracellular. {ECO:0000255}.
TRANSMEM 236 256 Helical. {ECO:0000255}.
TOPO_DOM 257 578 Cytoplasmic. {ECO:0000255}.
CARBOHYD 50 50 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 74 74 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 110 110 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 154 154 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 177 177 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 189 189 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 56 75 {ECO:0000269|PubMed:11485736}.
DISULFID 202 223 {ECO:0000269|PubMed:11485736}.
VARIANT 61 61 L -> V (in dbSNP:rs4252250).
{ECO:0000269|Ref.2}.
/FTId=VAR_016294.
VARIANT 69 69 W -> R (in IBD28).
{ECO:0000269|PubMed:24785691}.
/FTId=VAR_071663.
VARIANT 84 84 T -> I (in IBD28; dbSNP:rs137853580).
{ECO:0000269|PubMed:19890111}.
/FTId=VAR_063542.
VARIANT 91 91 Y -> C (in IBD28).
{ECO:0000269|PubMed:23839161,
ECO:0000269|PubMed:24785691}.
/FTId=VAR_071664.
VARIANT 101 101 R -> W (in IBD28; dbSNP:rs368287711).
{ECO:0000269|PubMed:23839161,
ECO:0000269|PubMed:24785691}.
/FTId=VAR_071665.
VARIANT 113 113 V -> I (in dbSNP:rs4252303).
{ECO:0000269|Ref.2}.
/FTId=VAR_016295.
VARIANT 117 117 R -> H (in IBD28; dbSNP:rs199989396).
{ECO:0000269|PubMed:23839161,
ECO:0000269|PubMed:24785691}.
/FTId=VAR_071666.
VARIANT 141 141 G -> R (in IBD28; dbSNP:rs137853579).
{ECO:0000269|PubMed:19890111}.
/FTId=VAR_063543.
VARIANT 159 159 S -> G (in dbSNP:rs3135932).
{ECO:0000269|Ref.2}.
/FTId=VAR_016296.
VARIANT 212 212 R -> Q (in dbSNP:rs4252273).
{ECO:0000269|Ref.2}.
/FTId=VAR_016297.
VARIANT 224 224 I -> V (in dbSNP:rs2228055).
/FTId=VAR_020004.
VARIANT 262 262 R -> C (in IBD28; dbSNP:rs149491038).
{ECO:0000269|PubMed:23839161,
ECO:0000269|PubMed:24785691}.
/FTId=VAR_071667.
VARIANT 351 351 R -> G (in dbSNP:rs2229113).
{ECO:0000269|PubMed:14702039,
ECO:0000269|PubMed:15489334,
ECO:0000269|PubMed:8120391,
ECO:0000269|Ref.2, ECO:0000269|Ref.6}.
/FTId=VAR_016298.
VARIANT 353 353 P -> S (in dbSNP:rs35235073).
/FTId=VAR_049175.
VARIANT 420 420 S -> L (in dbSNP:rs2229114).
{ECO:0000269|Ref.2}.
/FTId=VAR_016299.
STRAND 32 37 {ECO:0000244|PDB:1Y6K}.
STRAND 40 45 {ECO:0000244|PDB:1Y6K}.
STRAND 56 63 {ECO:0000244|PDB:1Y6K}.
STRAND 70 82 {ECO:0000244|PDB:1Y6K}.
HELIX 84 87 {ECO:0000244|PDB:1Y6K}.
HELIX 90 92 {ECO:0000244|PDB:1Y6K}.
STRAND 96 104 {ECO:0000244|PDB:1Y6K}.
HELIX 120 122 {ECO:0000244|PDB:1Y6K}.
STRAND 123 125 {ECO:0000244|PDB:1Y6K}.
STRAND 128 134 {ECO:0000244|PDB:1Y6K}.
STRAND 136 144 {ECO:0000244|PDB:1Y6K}.
STRAND 149 151 {ECO:0000244|PDB:1Y6K}.
HELIX 157 160 {ECO:0000244|PDB:1Y6K}.
STRAND 165 176 {ECO:0000244|PDB:1Y6K}.
STRAND 181 193 {ECO:0000244|PDB:1Y6K}.
STRAND 199 209 {ECO:0000244|PDB:1Y6K}.
STRAND 222 225 {ECO:0000244|PDB:1Y6K}.
HELIX 268 270 {ECO:0000244|PDB:5IXI}.
SEQUENCE 578 AA; 63003 MW; 54B183ABE84808DB CRC64;
MLPCLVVLLA ALLSLRLGSD AHGTELPSPP SVWFEAEFFH HILHWTPIPN QSESTCYEVA
LLRYGIESWN SISNCSQTLS YDLTAVTLDL YHSNGYRARV RAVDGSRHSN WTVTNTRFSV
DEVTLTVGSV NLEIHNGFIL GKIQLPRPKM APANDTYESI FSHFREYEIA IRKVPGNFTF
THKKVKHENF SLLTSGEVGE FCVQVKPSVA SRSNKGMWSK EECISLTRQY FTVTNVIIFF
AFVLLLSGAL AYCLALQLYV RRRKKLPSVL LFKKPSPFIF ISQRPSPETQ DTIHPLDEEA
FLKVSPELKN LDLHGSTDSG FGSTKPSLQT EEPQFLLPDP HPQADRTLGN REPPVLGDSC
SSGSSNSTDS GICLQEPSLS PSTGPTWEQQ VGSNSRGQDD SGIDLVQNSE GRAGDTQGGS
ALGHHSPPEP EVPGEEDPAA VAFQGYLRQT RCAEEKATKT GCLEEESPLT DGLGPKFGRC
LVDEAGLHPP ALAKGYLKQD PLEMTLASSG APTGQWNQPT EEWSLLALSS CSDLGISDWS
FAHDLAPLGC VAAPGGLLGS FNSDLVTLPL ISSLQSSE


Related products :

Catalog number Product name Quantity
U0229h CLIA Homo sapiens,Human,IL-2 receptor subunit alpha,IL-2R subunit alpha,IL2RA,IL-2-RA,IL2-RA,Interleukin-2 receptor subunit alpha,p55,TAC antigen 96T
E0229h ELISA kit Homo sapiens,Human,IL-2 receptor subunit alpha,IL-2R subunit alpha,IL2RA,IL-2-RA,IL2-RA,Interleukin-2 receptor subunit alpha,p55,TAC antigen 96T
E0229h ELISA Homo sapiens,Human,IL-2 receptor subunit alpha,IL-2R subunit alpha,IL2RA,IL-2-RA,IL2-RA,Interleukin-2 receptor subunit alpha,p55,TAC antigen 96T
U0229b CLIA Bos taurus,Bovine,IL-2 receptor subunit alpha,IL-2R subunit alpha,IL2RA,IL-2-RA,IL2-RA,Interleukin-2 receptor subunit alpha,p55,TAC antigen 96T
E0229b ELISA Bos taurus,Bovine,IL-2 receptor subunit alpha,IL-2R subunit alpha,IL2RA,IL-2-RA,IL2-RA,Interleukin-2 receptor subunit alpha,p55,TAC antigen 96T
E0229b ELISA kit Bos taurus,Bovine,IL-2 receptor subunit alpha,IL-2R subunit alpha,IL2RA,IL-2-RA,IL2-RA,Interleukin-2 receptor subunit alpha,p55,TAC antigen 96T
E1815h ELISA kit gp80,Homo sapiens,Human,IL-6 receptor subunit alpha,IL6R,IL-6R 1,IL-6R subunit alpha,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Membrane glycoprotein 80 96T
U1815h CLIA kit gp80,Homo sapiens,Human,IL-6 receptor subunit alpha,IL6R,IL-6R 1,IL-6R subunit alpha,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Membrane glycoprotein 80 96T
E1815h ELISA gp80,Homo sapiens,Human,IL-6 receptor subunit alpha,IL6R,IL-6R 1,IL-6R subunit alpha,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Membrane glycoprotein 80 96T
U1815h CLIA gp80,Homo sapiens,Human,IL-6 receptor subunit alpha,IL6R,IL-6R 1,IL-6R subunit alpha,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Membrane glycoprotein 80 96T
U2031h CLIA 582J2.1,Homo sapiens,Human,IL-4 receptor subunit alpha,IL4R,IL-4R subunit alpha,IL4RA,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha 96T
E2031h ELISA kit 582J2.1,Homo sapiens,Human,IL-4 receptor subunit alpha,IL4R,IL-4R subunit alpha,IL4RA,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha 96T
E2031h ELISA 582J2.1,Homo sapiens,Human,IL-4 receptor subunit alpha,IL4R,IL-4R subunit alpha,IL4RA,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha 96T
U2031h CLIA kit 582J2.1,Homo sapiens,Human,IL-4 receptor subunit alpha,IL4R,IL-4R subunit alpha,IL4RA,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha 96T
U2031m CLIA IL-4 receptor subunit alpha,Il4r,IL-4R subunit alpha,Il4ra,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha,Mouse,Mus musculus 96T
U2031r CLIA IL-4 receptor subunit alpha,Il4r,IL-4R subunit alpha,Il4ra,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha,Rat,Rattus norvegicus 96T
E1815m ELISA kit IL-6 receptor subunit alpha,Il6r,IL-6R 1,IL-6R subunit alpha,Il6ra,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Mouse,Mus musculus 96T
U1815m CLIA IL-6 receptor subunit alpha,Il6r,IL-6R 1,IL-6R subunit alpha,Il6ra,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Mouse,Mus musculus 96T
U1815m CLIA kit IL-6 receptor subunit alpha,Il6r,IL-6R 1,IL-6R subunit alpha,Il6ra,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Mouse,Mus musculus 96T
U2031m CLIA kit IL-4 receptor subunit alpha,Il4r,IL-4R subunit alpha,Il4ra,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha,Mouse,Mus musculus 96T
U1815r CLIA IL-6 receptor subunit alpha,Il6r,IL-6R 1,IL-6R subunit alpha,Il6ra,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Rat,Rattus norvegicus 96T
U2031r CLIA kit IL-4 receptor subunit alpha,Il4r,IL-4R subunit alpha,Il4ra,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha,Rat,Rattus norvegicus 96T
E2031m ELISA IL-4 receptor subunit alpha,Il4r,IL-4R subunit alpha,Il4ra,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha,Mouse,Mus musculus 96T
E2031m ELISA kit IL-4 receptor subunit alpha,Il4r,IL-4R subunit alpha,Il4ra,IL-4RA,IL-4R-alpha,Interleukin-4 receptor subunit alpha,Mouse,Mus musculus 96T
E1815r ELISA IL-6 receptor subunit alpha,Il6r,IL-6R 1,IL-6R subunit alpha,Il6ra,IL-6RA,IL-6R-alpha,Interleukin-6 receptor subunit alpha,Rat,Rattus norvegicus 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur